MedPageToday
MedPage Today) — An observational study of 175 health outcomes using Veterans Affairs (VA) data for nearly 2 million individuals uncovered new insights about possible risks and benefits of GLP-1 receptor agonists.
Over a median of 3.68 years…
Read More
GLP-1 Agents’ Risks and Benefits Broader Than Previously Thought
Johnathon Noren
07:21
MedPage Today) — An observational study of 175 health outcomes using Veterans Affairs (VA) data for nearly 2 million individuals uncovered new insights about possible risks and benefits of GLP-1 receptor agonists. Over a median of 3.68 years…
